Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion type Assertion NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_head.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion description "[Case subjects more often demonstrated >or=2 factors contributing to hyperbilirubinemia, including ABO blood group heterospecificity in which the mother had blood group O (47.7% vs 11.4%), positive direct Coombs test results (33.3% vs 4%), sibling treated with phototherapy (16.3% vs 5.4%), maternal circulating blood group antibodies (10.5 vs 0.7%), maternal diabetes mellitus (13.1% vs 6.4%), and maternal East Asian ethnicity (6.5% vs 1.3%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_provenance.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion evidence source_evidence_literature NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_provenance.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion SIO_000772 19858149 NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_provenance.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion wasDerivedFrom befree-20150227 NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_provenance.
- NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_assertion wasGeneratedBy ECO_0000203 NP219993.RAizEZ-UkUKJiUlJpErnTT-L7OunVLJT9FeTOoRbpdrO0130_provenance.